Tandlæge Iben Nue Sønderstrup ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.9% 2.4% 1.5% 1.9% 2.3%  
Credit score (0-100)  59 62 74 69 64  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 7.0 0.4 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  2,423 2,521 3,344 2,996 3,574  
EBITDA  668 806 1,069 514 448  
EBIT  443 578 825 256 192  
Pre-tax profit (PTP)  322.2 478.9 724.3 209.1 151.0  
Net earnings  251.3 373.5 564.9 163.0 117.8  
Pre-tax profit without non-rec. items  322 479 724 209 151  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  977 876 955 768 582  
Shareholders equity total  358 624 1,078 1,128 1,131  
Interest-bearing liabilities  1,451 974 50.5 0.0 0.0  
Balance sheet total (assets)  2,471 2,784 2,663 2,479 2,791  

Net Debt  1,386 424 -287 -479 -955  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,423 2,521 3,344 2,996 3,574  
Gross profit growth  17.7% 4.1% 32.6% -10.4% 19.3%  
Employees  4 5 5 4 4  
Employee growth %  0.0% 25.0% 0.0% -20.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,471 2,784 2,663 2,479 2,791  
Balance sheet change%  -9.6% 12.7% -4.4% -6.9% 12.6%  
Added value  443.0 577.9 824.9 256.1 192.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -450 -400 -236 -515 -511  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  18.3% 22.9% 24.7% 8.5% 5.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  17.0% 22.1% 30.3% 10.0% 7.3%  
ROI %  21.9% 30.1% 50.0% 18.2% 13.8%  
ROE %  108.1% 76.1% 66.4% 14.8% 10.4%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  14.6% 22.5% 40.6% 46.1% 41.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  207.6% 52.7% -26.8% -93.2% -213.2%  
Gearing %  405.2% 156.2% 4.7% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  7.2% 8.4% 19.7% 194.4% 291,434.5%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.3 0.7 0.5 0.7 0.9  
Current Ratio  0.4 0.7 0.5 0.7 0.9  
Cash and cash equivalent  64.8 549.7 337.3 478.9 955.4  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -516.3 -362.8 -594.6 -324.5 -108.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  111 116 165 64 48  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  167 161 214 128 112  
EBIT / employee  111 116 165 64 48  
Net earnings / employee  63 75 113 41 29